 Print page |
 Email page |
| FOR IMMEDIATE RELEASE |
August 5 , 2009 |
|
Media Contact: Randolph Fillmore, Florida Science Communications, (813) 850-7614 rfillmore@nasw.org Another Generic T3 ReleasedFalls Church, Va. (August 5, 2009) - Mylan Pharmaceuticals of West Virginia recently received FDA approval for generic T3 (Liothyronine Sodium Tablets USP, 5 mcg, 25 mcg and 50 mcg) as another alternative for Cytomel. There is already an additional generic T3 preparation approved this year from Coastal Pharmaceuticals. This latest addition comes at a time when Mylan is also being subjected to an FDA review of its manufacturing practices. However, there is no evidence of problems with the production of Mylan T4 or T3. Further information is available at: http://www.post-gazette.com/pg/09217/988560-28.stm http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm - Search for LIOTHYRONINE SODIUM # The American Thyroid Association (ATA) is the lead organization in promoting thyroid health and understanding thyroid biology. The ATA values scientific inquiry, clinical excellence, public service, education, collaboration, and collegiality. ATA members are physicians and scientists who work to enhance the understanding of thyroid physiology and pathophysiology, improve diagnosis and treatment of thyroid diseases, and promote the education of physicians, patients, and the public about thyroid cancer. Thyroid diseases are the most common disorders of the endocrine system, affecting almost 13 million Americans. |
